Promising Alzheimer’s drug posdinemab gets FDA fast-track status
Drug Target Review - 04-Feb-2025In Phase IIb trials, plasma biomarkers identify early-stage patients
Join the club for FREE to access the whole archive and other member benefits.
Largest healthcare company that develops medical devices, pharmaceuticals, and consumer packaged goods
At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 130 years, we have aimed to keep people well at every age and every stage of life. Today, as the world’s largest and most broadly based healthcare company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere.
Every day, our more than 130,000 employees across the world are blending heart, science and ingenuity to profoundly change the trajectory of health for humanity.
Visit website: https://www.jnj.com/
Details last updated 04-Feb-2019
In Phase IIb trials, plasma biomarkers identify early-stage patients
It will be available next year and is part of a series of advanced medical tools
Company is planning to begin clinical trials in the US in late 2024
NBTXR3 to enhance the effect of immunotherapies; plans for phase 3 trial in head and neck cancer
Biological clocks should make sure they're using 'causes' and not 'effects' of ageing